Now there is reason to hope for significant change, spurred by heightened awareness of the lack diversity in clinical trial patient populations, racial discrimination in US healthcare and COVID-19’s disproportionate toll on disadvantaged communities.
TORONTO, Ontario (PRWEB) January 18, 2021
Why is patient diversity in clinical trials so important? The lack of equity and representation of minority groups in biomedical research has been an open concern for many years, despite regulatory and private-sector initiatives to change, and awareness of the need to demonstrate the safety and efficacy of all products used in clinical trials in all population groups has grown in recent years. Now there is reason to hope for significant change, spurred by heightened awareness of the lack diversity in clinical trial patient populations, racial discrimination in US healthcare and COVID-19’s disproportionate toll on disadvantaged communities.
How can clinical researchers strike the correct balance of scientific and ethical imperatives as they seek to include a target patient cohort that is truly representative of the affected populations? Is it possible to secure a commitment from concrete action from internal and external stakeholders? What form should that commitment take? In this panel-led discussion — the first in a series of four — Syneos Health, the only fully integrated biopharmaceutical solutions organization, will bring together key stakeholders to evaluate how we can collectively illuminate a new path to equitable and inclusive clinical research.
Join expert speakers Stephen Keith, MD, MSPH, Medical Director, Syneos Health and Fabian Sandoval, MD, CEO & Research Director, Emerson Clinical Research Institute in a live webinar on Wednesday, January 27, 2021 at 12pm EST for the first of these conversations.
For more information, or to register for this event, visit Increasing Trial Diversity: Illuminating a New Path to Equitable and Inclusive Clinical Research.
Blazing a Trail to Clinical Trial Diversity Webinar Series
This four-part webinar series will identify obstacles that have to-date, and continue to, stifle appropriate patient diversity in clinical trials; unpack the organizational overhaul needed to effect change; share case studies where sponsors, patients and investigators have come together to overcome hurdles; and explore how policy innovations that might include government-led mandates and incentives can move the industry forward, together. Speakers include experts from the Association for Clinical Research Professionals (ACRP), Bristol Myers Squibb, Emory-Winship Cancer Center, Incyte Corporation, NCI Community Oncology Research Program (NCORP) and the Center for Medicine in the Public Interest.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
About Syneos Health
Syneos Health® is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.